Faron, which trades as Faron Pharmaceuticals Ltd (Oy in its Finnish form), is a clinical-stage biopharmaceutical company focused on immunotherapy. Its lead candidate, bexmarilimab, is designed to target a receptor on immune cells that tumours can exploit to evade the immune system. The drug …
GENinCode is a UK-based predictive genetics business focused on the prevention of cardiovascular disease, with an additional interest in ovarian cancer risk. It offers genetic risk tests based on blood or saliva samples through operations in the UK, Spain and the United States. Its …
hVIVO is a contract research organisation best known for human challenge trials, in which healthy volunteers are deliberately exposed to a pathogen in a controlled setting to test vaccines and antivirals. It runs quarantine facilities in London and has broadened its offering into early-phase …
The announcement relates to paraytec investment update brings portfolio progress into focus.
ImmuPharma is a UK-listed drug discovery and development company. Its lead asset, P140, is a peptide being explored as a treatment for autoimmune and inflammatory conditions, including lupus, and the company has US licensing partner Avion Pharmaceuticals for the programme. It is also developing …
Aptamer Group develops Optimer binders, which are engineered nucleic acid molecules designed to act as alternatives to antibodies. These binders can be used in research tools, diagnostics and therapeutic delivery. The company earns money through fee-for-service discovery programmes for partners in life sciences and …
Bioventix develops and supplies high-affinity sheep monoclonal antibodies for use in clinical diagnostics. Most of these antibodies are built into tests run on automated blood-testing machines in hospitals and laboratories, supplied by major in-vitro diagnostics companies. The company earns revenue in two ways: from …
The group is a specialist medical diagnostics business focused on food sensitivity and nutrition testing. Its main product lines are FoodPrint, its largest category, the Food Detective rapid test and CNSLab laboratory testing services. It sells in the UK, India, the Americas, Europe, Africa, …
Based in Cambridge, 4basebio manufactures synthetic DNA using a cell-free, enzymatic process rather than the traditional bacterial plasmid approach. Its main product, opDNA, is designed as starting material for genetic medicines, including gene therapies, genome editing, mRNA production and DNA vaccines. The company holds …
For much of the past two years, the shadow of the Competition and Markets Authority's investigation into the UK veterinary market has hung over CVS Group (LSE:CVSG). That chapter has now formally closed. The CMA published its final remedies order on 22 September, and …